Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

SELL
$8.01 - $8.64 $17,541 - $18,921
-2,190 Reduced 14.84%
12,567 $103,000
Q1 2024

May 15, 2024

SELL
$8.02 - $8.67 $6,680 - $7,222
-833 Reduced 5.34%
14,757 $125,000
Q4 2023

Jan 30, 2024

BUY
$7.78 - $8.62 $8,806 - $9,757
1,132 Added 7.83%
15,590 $128,000
Q3 2023

Oct 23, 2023

SELL
$7.85 - $8.94 $14,836 - $16,896
-1,890 Reduced 11.56%
14,458 $120,000
Q2 2023

Jul 24, 2023

SELL
$8.04 - $9.0 $4,775 - $5,346
-594 Reduced 3.51%
16,348 $136,000
Q1 2023

May 12, 2023

SELL
$7.57 - $8.37 $8,152 - $9,014
-1,077 Reduced 5.98%
16,942 $137,000
Q4 2022

Feb 10, 2023

BUY
$5.96 - $8.06 $13,451 - $18,191
2,257 Added 14.32%
18,019 $144,000
Q3 2022

Nov 09, 2022

BUY
$5.63 - $7.5 $88,740 - $118,215
15,762 New
15,762 $96,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $43.4B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Svb Wealth LLC Portfolio

Follow Svb Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Svb Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Svb Wealth LLC with notifications on news.